Media

  1. Home
  2. Media
  3. News
  4. JNC International completes NNPC/SNEPCo Donated Elekta Linear Accelerator at National Hospital Abuja

News

image description

JNC International completes NNPC/SNEPCo Donated Elekta Linear Accelerator at National Hospital Abuja

JNC International Ltd has completed the installation of the new cutting-edge cancer treatment machine at the National Hospital Abuja.

Speaking at the commissioning of the equipment by the Vice President ably represented by the Perm. Sec. Federal Ministry of Health, Abdullahi Mashi, on Friday 2nd August, 2019, the Chief Medical Director of the Hospital, Dr. Jaf Momoh, said the machine will reduce patient’s treatment waiting time from 16 minutes to two minutes.

The Elekta Synergy Linear Accelerator radiotherapy machine donated by the Nigeria National Petroleum Corporation (NNPC) and Shell Nigeria Exploration and Production Company (SNEPCo) enables treatment to focus on the cancer tumor and not impact other organs in the patient.

Momoh described the intervention by NNPC and SNEPCo as timely noting that “With this new machine, the hospital is poised for effective and efficient cancer treatment with no interruption during periods of routine equipment maintenance,” adding that indigent patients would enjoy subsidised treatment.

In his speech, Vice President Osinbajo, represented by the Permanent Secretary, Federal Ministry of Health, Alhaji Abdullahi Mashi, Osinbajo said “The increasing trend in the prevalence of cancer may be a reflection of lifestyles which goes to show that lifestyle modifications may go a long way in curtailing the scourge. He charged well-meaning Nigerians and organisations “to replicate what NNPC and Shell Nigeria have done in other health facilities to make cancer treatment easily accessible to patients.”

MD/CEO of JNC International, Mrs. Clare Omatseye, said the Elekta Synergy Platform 160 MLC Linear Accelerator is Nigeria’s first commissioned equipment with Volume Moderated Arc Therapy (VMAT) which delivers quicker treatment with overall lower doses to patients. She expressed her delight at this new acquisition, praising SNEPCo and NNPC partnership stating that these kind of gestures will help to combat medical tourism in Nigeria.